Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

40 results about "Anetoderma" patented technology

Anetoderma is a localized laxity of the skin with herniation or outpouching resulting from abnormal dermal elastic tissue.

Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation

The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and / or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation of food intake, stimulation of weight gain, or increasing body fat mass, or increasing body lean mass. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for the prophylaxis or treatment of cancer cachexia in an individual in need of such treatment. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for prophylaxis or treatment of cachexia in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to the use of a ghrelin splice variant-like compound or a pharmaceutically acceptable salt thereof for the preparation of a medicament for stimulation of appetite in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to a number of new ghrelin splice variant-like compounds and uses thereof, as well as to pharmaceutical compositions and medical packaging comprising the new ghrelin splice variant-like compounds.
Owner:MINTZ LIAT

Serotonin and norepinephrine reuptake inhibitor and uses thereof

InactiveUS20070015824A1Low level of undesirable side-effectsBiocideOrganic chemistryNorepinephrine reuptake inhibitorDepressant
Selective dual serotonin and norepinephrine reuptake inhibitors are provided. These compounds have a lower side-effect profile and are useful in compositions and products for use in treatment of a variety of conditions including depression, fibromyalgia, anxiety, panic disorder, agoraphobia, post traumatic stress disorder, premenstrual dysphoric disorder, attention deficit disorder, obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, autism, schizophrenia, obesity, anorexia nervosa, bulimia nervosa, Gilles de la Tourette Syndrome, vasomotor flushing, cocaine and alcohol addiction, sexual dysfunction, borderline personality disorder, fibromyalgia syndrome, diabetic neuropathic pain, chronic fatigue syndrome, pain, Shy Drager syndrome, Raynaud's syndrome, Parkinson's Disease, and epilepsy.
Owner:WYETH

Traditional Chinese medicinal composition for treating children anorexia as well as preparation method and application of traditional Chinese medicinal composition

The invention provides a traditional Chinese medicinal composition for treating children anorexia. The traditional Chinese medicinal composition mainly consists of the following medicinal raw materials: white hyacinth bean, Chinese yam, poria cocos, dark plum, concha ostreae, fructus citri sarcodactyli, fructus hordei germinatus, semen ziziphi spinosae, fructus ziziphi jujubae, arillus longan, fructus alpiniae oxyphyllae, mulberry, fructus crataegi and semen raphani. Furthermore, the traditional Chinese medicinal composition consists of the following medicinal raw materials (in parts by weight): 3-15 parts of white hyacinth bean, 1-10 parts of Chinese yam, 3-15 parts of poria cocos, 1-8 parts of dark plum, 1-8 parts of concha ostreae, 1-8 parts of fructus citri sarcodactyli, 1-8 parts of fructus hordei germinatus, 3-15 parts of semen ziziphi spinosae, 1-8 parts of fructus ziziphi jujubae, 1-8 parts of arillus longan, 1-8 parts of fructus alpiniae oxyphyllae, 1-8 parts of mulberry, 1-8 parts of fructus crataegi and 1-10 parts of semen raphani. The composition disclosed by the invention has functions of tonifying stomach and spleen, boosting immunity and activity of children, tonifying brain and improving intelligence, and the like.
Owner:ZHEJIANG ASEN PHARMA

Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation

The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and / or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation of food intake, stimulation of weight gain, or increasing body fat mass, or increasing body lean mass. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for the prophylaxis or treatment of cancer cachexia in an individual in need of such treatment. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for prophylaxis or treatment of cachexia in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to the use of a ghrelin splice variant-like compound or a pharmaceutically acceptable salt thereof for the preparation of a medicament for stimulation of appetite in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to a number of new ghrelin splice variant-like compounds and uses thereof, as well as to pharmaceutical compositions and medical packaging comprising the new ghrelin splice variant-like compounds.
Owner:MINTZ LIAT

Use of Ghrelin Splice Variant for Treating Cachexia and/or Anorexia and/or Anorexia-Cachexia and/or Malnutrition and/or Lipodystrophy and/or Muscle Wasting and/or Appetite-Stimulation

The present disclosure relates, in one aspect, to use of ghrelin splice variant or an analogue thereof for the preparation of a medicament for one or more of: treatment and / or prevention of loss of body weight and body fat, prophylaxis or treatment of cachexia, stimulation of appetite, stimulation of food intake, stimulation of weight gain, or increasing body fat mass, or increasing body lean mass. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for the prophylaxis or treatment of cancer cachexia in an individual in need of such treatment. Another aspect relates to the use of a ghrelin splice variant-like compound for the preparation of a medicament for prophylaxis or treatment of cachexia in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to the use of a ghrelin splice variant-like compound or a pharmaceutically acceptable salt thereof for the preparation of a medicament for stimulation of appetite in an individual by administering a subcutaneous dosage of said medicament to the individual. A further aspect relates to a number of new ghrelin splice variant-like compounds and uses thereof, as well as to pharmaceutical compositions and medical packaging comprising the new ghrelin splice variant-like compounds.
Owner:MINTZ LIAT

Cachexia prevention supplement

InactiveUS20100189816A1Promoting muscle protein synthesisBiocideVitamin food ingredientsEicosapentaenoic acidGeneral diet
The invention provides for a nutritional composition comprising from 0.1 to 10 g of eicosapentaenoic acid or a derivative thereof based on 100 kcal of the total composition; and from 0.1 to 10 g of a phytochemical or a mixture thereof based on 100 kcal of the total composition, for a use as a medicament for the treatment and / or prevention of cachexia and / or anorexia. The composition is particularly useful in the prevention of cachexia and is administered almost without any additional macronutrients in order to avoid a negative impact on the general diet of the patient.
Owner:FRESENIUS KABI DEUT GMBH

Compound diet capable of removing fat, nourishing brain and improving eyesight

The invention discloses a compound diet capable of removing fat, nourishing the brain and improving eyesight. The compound diet capable of removing the fat, nourishing the brain and improving the eyesight is prepared from the following raw materials in parts by weight: 3-5 parts of flaxseed oil microcapsule powder, 10-15 parts of an oat extract, 8-12 parts of a dried small shrimp extract, 3-5 parts of a huckleberry extract, 10-15 parts of a spinach extract, 15-20 parts of a soybean extract, 2-4 parts of soybean oligosaccharides, 10-15 parts of millet, 6-8 parts of walnut kernels, 3-7 parts of Chinese wolfberry fruits, 15-25 parts of honey, 5-10 parts of an aqueous solution of hydroxypropyl methylcellulose, and 40-60 parts of water. The compound diet has the effects of nourishing the cranial nerves, promoting intelligence development, improving memory, preventing senile dementia, preventing amblyopia and night blindness, relieving asthenopia, promoting intestinal probiotic proliferation, correcting anorexia in the children, correcting effects of calcium deficiency on growth and development in the children, preventing osteoporosis caused by calcium deficiency in the elderly, and so on.
Owner:杨涵

Traditional Chinese herbal medicine for treating cholecystitis, pancreatitis, chronic gastritis and anorexia

The invention discloses a traditional Chinese herbal medicine for treating cholecystitis, pancreatitis, chronic gastritis and anorexia, belonging to a traditional Chinese medicine. The invention aims to provide an oral traditional Chinese herbal medicine with short treatment course, rapid response, high treatment rate, treatment in principal and secondary aspects and hard recurrence for treating symptoms caused by the cholecystitis, the pancreatitis and the chronic gastritis, such as ache, anorexia, nausea, vomiting, dyspepsia, and the like. The traditional Chinese herbal medicine for treating cholecystitis, pancreatitis, chronic gastritis and anorexia is prepared by crashing and mixing the following raw materials: 3-10 alpine yallow herb, 0.5-5 henry currant roots, 0.5-5 polyporus lucidus, 0.5-5 babylon weeping willow root bark, 0.5-5 madder roots, 0.5-5 sargentg loryvine and 3-10 brush-cherry seeds. The invention has the advantages of short treatment course, rapid pain relief, remarkable curative effect, convenient taking, and the like and can treat diseases, such as cholecystitis, pancreatitis, chronic gastritis and anorexia.
Owner:乔福军

Traditional Chinese medicine composition for treating child anorexia and preparation method of traditional Chinese medicine composition for treating child anorexia

The invention relates to a traditional Chinese medicine composition for treating child anorexia and a preparation method of the traditional Chinese medicine composition for treating child anorexia. The traditional Chinese medicine composition is prepared from 12 kinds of raw material medicine materials of radix codonopsis, bighead atractylodes rhizomes, radix ophiopogonis, polygonatum odoratum, herba dendrobii, haws, white peony roots, dried orange peel, Chinese yams, endothelium corneum gigeriae galli, striga asiatica and licorice roots through technologies of performing pretreatment, performing decoction, performing ethanol precipitation, performing concentration, performing drying and the like. The traditional Chinese medicine composition has the efficacy of benefitting qi, invigoratingthe spleen, nourishing yin, nourishing the stomach and resolving food stagnation, and is used for diseases of anorexia or apastia caused by infantile deficiency and weakness of spleen qi and defectsof stomach yin, lack of lustre in complexion, loss of spirit, emaciated or puffy bodies, easiness to sweat, loose stool or constipation, or retention of food and drink, abdominal fullness and distention and the like. The animal experiment result indicates that the traditional Chinese medicine composition disclosed by the invention can increase the food intake of an anorexia model bandicoot, can promote secretion of gastrin of the gastric antrum part, can achieve the effect of treating both manifestation and root cause of the child anorexia, and has great broad market development prospects.
Owner:LUNAN PHARMA GROUP CORPORATION

Traditional Chinese medicine composition for treating child food dyspepsia spleen deficiency type anorexia and application of traditional Chinese medicine composition

InactiveCN110420300APromote osmotic absorptionBe kind to the stale product of wine and foodDigestive systemPlant ingredientsSide effectMassage
The invention discloses a traditional Chinese medicine composition for treating child food dyspepsia spleen deficiency type anorexia and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition for treating the child food dyspepsia spleen deficiency type anorexia is prepared from the following bulk pharmaceutical chemicals in parts by weight: 30-60parts of fructus crataegi, 10-30 parts of medicated leaven, 15-35 parts of fructus hordei germinatus, 10-30 parts of pericarpium citri reticulatae, 20-40 parts of poria cocos and 15-40 parts of rhizome atractylodis macrocephalae, a dosage form of the traditional Chinese medicine composition is an external use dosage form, the an external use dosage form is an ointment, an aerosol, a spray or a linimentum, and the traditional Chinese medicine composition is used as an external medium in the medical massage process. The traditional Chinese medicine composition has functions of promoting digestion to eliminate stagnation and strengthening spleen to transport and clearing damp, and can be used for treating the child food dyspepsia spleen deficiency type anorexia. The traditional Chinese medicine composition for treating child food dyspepsia spleen deficiency type anorexia has the advantages that the traditional Chinese medicine composition is used as the medium for external use for treating the child food dyspepsia spleen deficiency type anorexia in a medical massage mode, the therapeutic effect is very remarkable, the traditional Chinese medicine composition is safe to human bodies, and no side effect exists.
Owner:慈幼(上海)健康管理咨询有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products